foto1 foto2 foto3 foto4 foto5


Our news

  • 18/07/2019: Pharegis implemented optimized procedures for state registration of pharmaceuticals in Eurasian Economic Union.
  • 20/06/2019: Pharegis updated timelines and practical approaches for Russian and EEU GMP inspection applications and procedures.
  • 03/04/2019:  Renewed general monographs of Russian state pharmacopeia XIV ed. have been analyzed.

Contact us

enarzh-CNfrdeiwitjakoptruessv

Regulatory Events Russia

September 2020
S M T W T F S
30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3
October 2020
S M T W T F S
27 28 29 30 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Russian Regulatory News

Drug registration in Ukraine, Kazakhstan, Belarus, Uzbekistan, Azerbaijan; regulatory consulting and clinical studies in CIS by CRO Pharegis

Registration of pharmaceuticals in EEU countries, Ukraine and Georgia

Regulatory systems for medical drugs and medical devices in Russia, Kazakhstan, Belarus, Armenia, Kyrgyzstan as members of Eurasian Economical Union (EEU) are expected to be changed with implementation of Mutual Recognition Procedure for EEU country members that will be actual already in 2016. 

Understanding your business and having experience in EEU (CIS) countries as well as Georgia and Ukraine, we can handle your registration activities to plan and minimize timeline for getting access to those countries’ promising markets.

Also we can handle communication activities regarding post-registration quality issues, Health authorities requests as well as pharmacovigilance/materiovigilance in those countries that you could focus on high priority projects.

SHARE THIS BY:

News and press releases

  • Guideline on registry-based studies - launch of public consultation, , 24/09/2020
  • How incidents with medicines are managed in the EU – a ten-year analysis, , 23/09/2020
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2020, CHMP, 18/09/2020
  • New oral treatment for moderate to severe atopic dermatitis, CHMP, 18/09/2020